Mensing
David Mensing, Hilton, NY US
Patent application number | Description | Published |
---|---|---|
20110242583 | In-Line System for the Validation of a Page Description Language within a Print Data Stream - The present specification discloses a printer in which the printer performs a first analysis of a print job data to identify a page description language and if no page description language is identified by the first analysis, performs additional processing activities, including but not limited to spooling and parsing, concurrent to a second analysis of the entire print job data to identify a page description language. | 10-06-2011 |
20130268926 | Tools And Methods For Customizing Multi-Function Devices - Apparatus are provided that includes a multi-function device that is configured to perform a plurality of functions relating to manipulating a document. The multi-function device can have a display configured to display interface tool for facilitating the customization of a function of the multi-function device. The interface tools allow a user to communicate with the multi-function device to enter information relating to the customized function. The custom application can be configured to be installed on the multi-function device, and the custom application is used to customize the multi-function device. | 10-10-2013 |
Glennys A. Mensing, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20100262077 | Micro-Fluidic Device For Drug Delivery - A microfluidic device is provided for delivering a drug to an individual. The microfluidic device includes a body that defines a reservoir for receiving the drug therein. A valve interconnects the reservoir to an output needle that is insertable into the skin of an individual. A pressure source urges the drug from the reservoir toward the needle. The valve is movable between a closed position preventing the flow of the drug from the reservoir to the output needle and an open position allowing for the flow of the drug from the reservoir to the output needle in response to a predetermined condition in the physiological fluids of the individual. | 10-14-2010 |
Heinrich Mensing, Langen DE
Patent application number | Description | Published |
---|---|---|
20130112136 | DEVICE FOR APPLYING FLUID MEDIA - The invention relates to a device for applying fluid media to material that is moved in a web-like manner, in particular for applying hot-melt adhesive ( | 05-09-2013 |
Jeffrey Mensing, Blaine, MN US
Patent application number | Description | Published |
---|---|---|
20150047538 | HEIGHT ADJUSTABLE DESK SYSTEM AND METHOD - A height adjustable desk can include a work surface; and at least one leg assembly connected to the work surface. The at least one leg assembly can include: a first member; and a second member moveable relative to the first member along a longitudinal axis; and a counterbalance mechanism connected to the desk and configured to counteract a force exerted on the work surface. The counterbalance mechanism can include: a wheel; a gas spring having a cylinder and a moveable piston; a wheel moveably connected to the gas spring; and the tension member is connected to the leg assembly. | 02-19-2015 |
Jeffrey Mensing, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20110193524 | MOBILE COMPUTING DEVICE CHARGING AND NETWORKING SYSTEM AND METHOD - Systems and methods for charging and/or networking mobile computing devices. A cart for storing, charging, and/or networking mobile computing devices. A portable interface between a mobile computing device and a cart. A docking station module having a plurality of docking stations. | 08-11-2011 |
20130068916 | RECLINING STAND SYSTEM AND METHOD - A stand useful for supporting one or more electronic displays. A stand useful for allowing one or more displays to be positioned at a wide variety of angles relative to a support surface. A stand that allows for the displays to be positioned at relatively extreme inclined angles. A stand useful for allowing an electronic display to be positioned closer to or away from a user while the angle is being adjusted. Methods of using such stands. | 03-21-2013 |
20130270404 | Multi-Axis Pivot System and Method - Some embodiments provide a pivot mechanism and/or system that includes a support member defining a cavity and an extension member at least partially located within the cavity. In some cases one or more inner surfaces of the cavity can provide one or more pivots defining multiple pivot axes about which the extension member is generally pivotable through corresponding pivot ranges. The extent of the pivot ranges can be defined by the cavity within the support member. In some cases cooperating clamp members engage the extension member and the support member to retain the extension member within the cavity. The clamp members may also include sliding surfaces that slidingly engage with the support member to provide frictional resistance to pivoting movement of the extension member. Electronic display pivoting and positioning systems are also provided as are methods for positioning and pivoting electronic displays. | 10-17-2013 |
Jeffrey R. Mensing, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20120019990 | BRAKE STAND SYSTEMS - A stand for an electronic display. The stand includes a brake mechanism to selectively fix the position of the display at a desired vertical position. An actuator proximate an outer edge of the display to selectively lock and unlock the brake mechanism. A brake mechanism locked and unlocked by tilting a display. | 01-26-2012 |
20140104806 | Brake Stand Systems - A stand for an electronic display. The stand includes a brake mechanism to selectively fix the position of the display at a desired vertical position. An actuator proximate an outer edge of the display to selectively lock and unlock the brake mechanism. A brake mechanism locked and unlocked by tilting a display. | 04-17-2014 |
Jeffrey Randall Mensing, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20100096515 | Convertible Display Stand System and Method - A convertible mounting system for selectively positioning a flat panel display on either a generally horizontal surface or a generally vertical surface. In some embodiments, the convertible mounting system includes a first mount portion and a second mount portion. The first mount portion cooperates with the second mount portion in a first orientation to position a flat panel display on a generally horizontal surface. The first mount portion also cooperates with the second mount portion in a second orientation to position the flat panel display on a generally vertical surface. | 04-22-2010 |
Jeffrey Randall Mensing, Blaine, MN US
Patent application number | Description | Published |
---|---|---|
20160029783 | HEIGHT ADJUSTABLE DESK SYSTEM AND METHOD - A height adjustable desk can include a work surface; and at least one leg assembly connected to the work surface. The at least one leg assembly can include: a first member; and a second member moveable relative to the first member along a longitudinal axis; and a counterbalance mechanism connected to the desk and configured to counteract a force exerted on the work surface. The counterbalance mechanism can include: a wheel; a gas spring having a cylinder and a moveable piston; a wheel moveably connected to the gas spring; and the tension member is connected to the leg assembly. | 02-04-2016 |
Marcus Mensing, Berlin DE
Patent application number | Description | Published |
---|---|---|
20100086757 | Method for coating a component - A method is provided for coating a component with a multilayer ceramic coating in which the individual layers of the ceramic coating are applied covering one another on the component, and in which ceramic particles are supplied to a coating burner, melted partly or completely by the coating burner, and deposited on the component. The ceramic particles have a particle size, which increases from layer to layer, and are supplied to the coating burner. Furthermore, a multilayer ceramic coating and a component which has with a multilayer ceramic coating are provided. | 04-08-2010 |
20100255200 | Method for the production of turbine components - The invention relates to a method for production of turbine components having at least one flow body, which has cooling air outlet openings arranged in the area of its trailing edge with the flow body, for example a blade section, being provided with an in particular ceramic coating by spraying coating. According to the invention, before the coating is applied, the cooling air outlet openings are completely covered by a covering strip which is composed of a material which is resistant to the coating process. | 10-07-2010 |
Sven Mensing, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20120225080 | HUMAN ANTIBODIES THAT BIND THE P40 SUBUNIT OF HUMAN IL-12/IL-23 AND USES THEREFOR - The invention provides human antibodies that bind to the p40 subunit of human IL-12 and/or IL-23. The invention further provides a method of treating psoriasis in a subject by administering to a subject an antibody that binds to the p40 subunit of IL-12 and/or IL-23. | 09-06-2012 |
20130102525 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 04-25-2013 |
20130102526 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 04-25-2013 |
20130102557 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 04-25-2013 |
20130102558 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 04-25-2013 |
20140024579 | METHODS FOR TREATING HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 01-23-2014 |
20140057835 | METHODS FOR TREATING HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 02-27-2014 |
20140093516 | HUMAN ANTIBODIES THAT BIND THE P40 SUBUNIT OF HUMAN IL-12/IL-23 AND USES THEREFOR - The invention provides human antibodies that bind to the p40 subunit of human IL-12 and/or IL-23. The invention further provides a method of treating psoriasis in a subject by administering to a subject an antibody that binds to the p40 subunit of IL-12 and/or IL-23. | 04-03-2014 |
20140107016 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 04-17-2014 |
20140107017 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 04-17-2014 |
20140323395 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 10-30-2014 |
20150024999 | Methods for Treating HCV - The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. | 01-22-2015 |
20150196615 | Methods for Treating HCV - The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). | 07-16-2015 |